%0 Journal Article
%T Pulmonary hypertension across the spectrum of left heart and lung disease.
%A Borlaug BA
%A Larive B
%A Frantz RP
%A Hassoun P
%A Hemnes A
%A Horn E
%A Leopold J
%A Rischard F
%A Berman-Rosenzweig E
%A Beck G
%A Erzurum S
%A Farha S
%A Finet JE
%A Highland KB
%A Jacob M
%A Jellis C
%A Mehra R
%A Renapurkar R
%A Singh H
%A Tang WHW
%A Vanderpool R
%A Wilcox J
%A Yu S
%A Hill N
%J Eur J Heart Fail
%V 0
%N 0
%D 2024 Jun 4
%M 38837273
%F 17.349
%R 10.1002/ejhf.3302
%X <B>OBJECTIVE: </B>Patients with pulmonary hypertension (PH) are grouped based upon clinical and haemodynamic characteristics. Groups 2 (G2, left heart disease [LHD]) and 3 (G3, lung disease or hypoxaemia) are most common. Many patients display overlapping characteristics of heart and lung disease (G2-3), but this group is not well-characterized.<BR><B>RESULTS: </B>Patients with PH enrolled in the prospective, NHLBI-sponsored PVDOMICS network underwent intensive clinical, biomarker, imaging, gas exchange and exercise phenotyping. Patients with pure G2, pure G3, or overlapping G2-3 PH were compared across multiple phenotypic domains. Of all patients with predominant G2 (n = 136), 66 (49%) were deemed to have secondary lung disease/hypoxaemia contributors (G2/3), and of all patients categorized as predominant G3 (n = 172), 41 (24%) were judged to have a component of secondary LHD (G3/2), such that 107 had G2-3 (combined G2/3 and G3/2). As compared with G3, patients with G2 and G2-3 were more obese and had greater prevalence of hypertension, atrial fibrillation, and coronary disease. Patients with G2 and G2-3 were more anaemic, with poorer kidney function, more cardiac dysfunction, and higher N-terminal pro-B-type natriuretic peptide than G3. Lung diffusion was more impaired in G3 and G2-3, but commonly abnormal even in G2. Exercise capacity was severely and similarly impaired across all groups, with no differences in 6-min walk distance or peak oxygen consumption, and pulmonary vasoreactivity to nitric oxide did not differ. In a multivariable Cox regression model, patients with G2 had lower risk of death or transplant compared with G3 (hazard ratio [HR] 0.51, 95% confidence interval [CI] 0.30-0.86), and patients with G2-3 also displayed lower risk compared with G3 (HR 0.57, 95% CI 0.38-0.86).<BR><B>CONCLUSIONS: </B>Overlap is common in patients with a pulmonary or cardiac basis for PH. While lung structure/function is clearly more impaired in G3 and G2-3 than G2, pulmonary abnormalities are common in G2, even when clinically judged as isolated LHD. Further study is required to identify optimal systematic evaluations to guide therapeutic innovation for PH associated with combined heart and lung disease.<BR><B>BACKGROUND: </B>ClinicalTrials.gov NCT02980887.